Traditional Chinese Medicine Ganshuang Granules Attenuate CCl 4 ‐Induced Hepatic Fibrosis by Modulating Gut Microbiota

Author(s):  
Jie Zhao ◽  
Jing Miao ◽  
Xin Wei ◽  
Liying Guo ◽  
Peng Li ◽  
...  
2021 ◽  
Vol 12 ◽  
Author(s):  
Yumeng Zhang ◽  
Min Zhao ◽  
Xue Jiang ◽  
Qiaoyu Qiao ◽  
Tingting Liu ◽  
...  

Hepatic fibrosis (HF) is a typical consequence in the development of multiple chronic liver diseases, which is intimately related to the composition and metabolic status of gut microbiota. A myriad of evidence has indicated that traditional Chinese medicine can treat HF by regulating gut microbiota. Yinchen Wuling powder (YCWLP) is a famous traditional Chinese medicine prescription, which has been used to relieve liver diseases for thousands of years. YCWLP has demonstrated protective function on HF, but its effect on the alterations of gut microbiota is still unclear, and its explicit therapeutic mechanism also needs to be further elucidated. In this study, 16S rRNA gene sequencing and fecal metabolomics analysis were combined to investigate the influence of YCWLP on gut microbiota in HF rats and the interactions between gut microbiota and host metabolism. The results showed that YCWLP treatment significantly improved the disorder of multiple organ indices, HF-related cytokines and plasma LPS induced by HF. Masson’s trichrome stainings also showed that YCWLP treatment could significantly alleviate the severity of HF in rats. Additionally, YCWLP could reverse the significant changes in the abundance of certain genera closely related to HF phenotype, including Barnesiella [Ruminococcus] and Christensenella. Meanwhile, YCWLP significantly increased the abundance of Bifidobacterium, Coprococcus and Anaerostipes, which are closely related to butyrate production. Metabolomics and Spearman’s correlation analysis showed that YCWLP could regulate the disorder of arginine biosynthesis, sphingolipid metabolism and alanine, aspartate and glutamate metabolism in HF rats, and these regulations were intimately related to Barnesiella, [Ruminococcus], Christensenella, Coprococcus and Anaerostipes. By explaining the biological significance of the above results, we concluded that YCWLP might ameliorate HF by regulating the imbalance of gut microbiota, increasing the abundance of butyrate-producing bacteria to reduce ammonia production, promote ammonia degradation, and regulate pro-inflammatory cytokines and immune function.


2021 ◽  
Vol 16 (1) ◽  
Author(s):  
Tian-Yi Cheng ◽  
Jia-Xin Li ◽  
Jing-Yi Chen ◽  
Pei-Ying Chen ◽  
Lin-Rui Ma ◽  
...  

AbstractCoronary heart disease (CHD) is a common ischaemic heart disease whose pathological mechanism has not been fully elucidated. Single target drugs, such as antiplatelet aggregation, coronary artery dilation and lipid-lowering medicines, can relieve some symptoms clinically but cannot effectively prevent and treat CHD. Accumulating evidence has revealed that alterations in GM composition, diversity, and richness are associated with the risk of CHD. The metabolites of the gut microbiota (GM), including trimethylamine N-oxide (TMAO), short-chain fatty acids (SCFAs) and bile acids (BAs), affect human physiology by activating numerous signalling pathways. Due to the advantage of multiple components and multiple targets, traditional Chinese medicine (TCM) can intervene in CHD by regulating the composition of the GM, reducing TMAO, increasing SCFAs and other CHD interventions. We have searched PubMed, Web of science, Google Scholar Science Direct, and China National Knowledge Infrastructure (CNKI), with the use of the keywords “gut microbiota, gut flora, traditional Chinese medicine, herbal medicine, coronary heart disease”. This review investigated the relationship between GM and CHD, as well as the intervention of TCM in CHD and GM, and aims to provide valuable insights for the treatments of CHD by TCM.


2019 ◽  
Vol 10 (9) ◽  
pp. 5886-5897 ◽  
Author(s):  
Wan Qu ◽  
Shuo Liu ◽  
Weijie Zhang ◽  
Huawei Zhu ◽  
Qian Tao ◽  
...  

Gut microbiota dysbiosis is a recognized contributing factor to many noncommunicable diseases, but more evidence is still needed to illustrate its causative impact on mental and brain health disorders and mechanism(s) for targeted mitigation.


Medicine ◽  
2020 ◽  
Vol 99 (38) ◽  
pp. e22233
Author(s):  
Yujiao Zheng ◽  
Qiyou Ding ◽  
Lili Zhang ◽  
Xiaowen Gou ◽  
Yu Wei ◽  
...  

2019 ◽  
Vol 2019 ◽  
pp. 1-8 ◽  
Author(s):  
Wenfeng Xu ◽  
Shuo Xu ◽  
Shanshan Zhang ◽  
Xuejun Wu ◽  
Pengfei Jin

Niuhuang Jiedu tablet (NJT), a realgar (As2S2) containing Traditional Chinese Medicine (TCM), is a well-known formula. The safety of NJT is of growing concern since arsenic (As) is considered as one of the most toxic elements. NJT was demonstrated to be safer than realgar by our previous experiments and some other studies. The toxicity of realgar has been shown to be related to the amount of soluble or bioaccessible arsenic. In this study, the influences of the other TCMs in NJT on the bioaccessibility of arsenic from realgar, and the roles of gut microbiota during this process were investigated in vitro. Results showed that Dahuang (Rhei Radix et Rhizoma), Huangqin (Scutellariae Radix), Jiegeng (Platycodonis Radix), and Gancao (Glycyrrhizae Radix et Rhizoma) could significantly reduce the bioaccessibility of arsenic from realgar in artificial gastrointestinal fluids. Gut microbiota played an important role in decreasing the bioaccessibility of realgar because it was demonstrated to be able to absorb the soluble arsenic from realgar in the incubation medium. Dahuang, Huangqin, and Jiegeng could modulate the gut microbiota to enhance its arsenic absorption activity.


2021 ◽  
Vol 133 ◽  
pp. 110857
Author(s):  
Hai-Yu Zhang ◽  
Jia-Xing Tian ◽  
Feng-Mei Lian ◽  
Min Li ◽  
Wen-Ke Liu ◽  
...  

2020 ◽  
Author(s):  
Xudong Liu ◽  
You-Ming Tang ◽  
Ping Lv ◽  
Zhuang-Zhi Zhao ◽  
Xin-Jie Xu ◽  
...  

Abstract Background DaHuangZheChong pill (DHZCP) is a formula of traditional Chinese medicine, which has been written into the guideline for the prevention and treatment of hepatic fibrosis in China. The study was aim to investigate the anti-fibrotic effects and the potential mechanisms of DHZCP revolving around the TGF-β pseudo receptor, bone morphogenic protein and activin membrane-bound inhibitor (BAMBI) in hepatic stellate cells (HSCs). Materials and Methods Wistar rats were given with CCL4 for four weeks to establish hepatic fibrosis model. Then the rats were given normal saline or DHZCP decoction six weeks. the pathology of liver tissue was analyzed, the expression of Toll-like receptor 4 (TLR4), myeloid differentiation factor 88 (MyD88), BAMBI, and NF-κB were detected. In vitro, the associated signal molecules about LPS-activated NF-κB were also analyzed by immunohistochemistry, western blot, or electrophoretic mobility shift assay (EMSA) in cultured HSC-T6 cells . Results The DHZCP showed significant effects on improving fibrosis stage of liver tissue and inhibiting primary HSCs activation. The protein expression of TLR4/MyD88 was lower (P was both < 0.05), BAMBI was higher in DHZCP group than model control (MC) group (P < 0.05) in primary HSCs. In HSC-T6 cells, the activity of NF-κB was lower (P < 0.001), and BAMBI was higher (P < 0.05) in DHZCP added LPS group than in LPS group. Conclusion These results suggested that DHZCP alleviates hepatic fibrosis that was maybe associated with inhibiting activation of NF-κB induced by LPS, and upregulating BAMBI expression in HSCs.


2021 ◽  
Author(s):  
Haohui Liu ◽  
Meihui Xu ◽  
Kai Yee Toh ◽  
Chun Wie Chong ◽  
Jeremy Fung Yen Lim ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document